Description

Tagrix (Osimertinib) 80mg

Tagrix (Osimertinib) is a medication used to treat certain types of lung cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs) and works by inhibiting the activity of a specific enzyme called EGFR.

Indications

Tagrix is prescribed for the following conditions:

1. Advanced non-small cell lung cancer (NSCLC) with a mutation of the EGFR gene (Exon 19 deletion or L858R mutation).

2. In combination with other chemotherapy drugs for advanced NSCLC.

Dosage and Administration

The recommended dosage of Tagrix is as follows:

– Oral tablet: 80 mg once daily, to be taken with food.

Side Effects

Tagrix may cause side effects, although not everyone will experience them. Common side effects may include:

– Rash

– Nausea

– Diarrhea

– Headache

– Loss of appetite

– Fatigue

– Muscle pain

– Joint pain

– Hair loss

If you experience any severe or persistent side effects, you should inform your healthcare provider promptly.

Precautions

Before starting Tagrix, tell your healthcare provider about all your medical conditions, including:

– Liver or kidney disease

– Heart problems

– Breathing difficulties

– Diabetes

– Low white blood cell count

– A history of bleeding problems

– Pregnancy or breastfeeding

Tagrix may also interact with other medications, so it is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements.

Conclusion

Tagrix (Osimertinib) 80mg is a medication uses to treat certain types of lung cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs) and works by inhibiting the activity of a specific enzyme called EGFR. Tagrix is prescribed for advanced non-small cell lung cancer (NSCLC) with a mutation of the EGFR gene. It is important to consult with your healthcare provider before starting Tagrix  to discuss potential side effects and to ensure it is the right medication for you.